Search tips
Search criteria 


Logo of jclinneuroJournal of Clinical NeurologyAboutFor Contributorse-SubmissionThis Article
J Clin Neurol. 2007 March; 3(1): 57–61.
Published online 2007 March 20. doi:  10.3988/jcn.2007.3.1.57
PMCID: PMC2686926

Striopallidodentate Calcification and Progressive Supranuclear Palsy-Like Phenotype in a Patient with Idiopathic Hypoparathyroidism

Tae-Won Kim, M.D., In-Seok Park, M.D., Sung-Hoon Kim, M.D., Kwang-Soo Lee, M.D., Yeong-In Kim, M.D., and Joong-Seok Kim, M.D.corresponding author


We present a 77-year-old woman with levodopa-nonresponsive parkinsonism, dementia, and supranuclear gaze palsy on vertical and horizontal gaze. Laboratory findings were consistent with idiopathic hypoparathyroidism, and brain computed tomography showed extensive bilateral calcifications of the basal ganglia, centrum semiovale, dentate nuclei, and cerebellar white matter. These results illustrate that striopallidodentate calcification due to hypoparathyroidism may present with symptoms mimicking progressive supranuclear palsy.

Keywords: Striopallidodentate calcification, Idiopathic hypoparathyroidism, Progressive supranuclear palsy

Fahr's disease is characterized by idiopathic calcification of the basal ganglia, dentate nuclei of the cerebellum, and the centrum semiovale,1,2 and is occasionally associated with either hypoparathyroidism or pseudohypoparathyroidism.1 Both familial and nonfamilial forms have been reported, with autosomal-dominant inheritance predominating.3-5 Clinically, it may present with movement disorders such as rigidity, hypokinesia, tremor, choreoathetosis, and ataxia, as well as behavioral disturbances such as dementia and mood disorders.5-9

Whilst parkinsonism is a well-recognized symptom associated with striopallidodentate calcification, prominent postural instability with frequent falling down and supranuclear gaze palsy, which are the characteristic clinical manifestations of progressive supranuclear palsy (PSP), have been very rarely reported.10-12

We describe a patient with bilateral striopallidodentate calcification who presented with progressive gait disturbance, prominent postural instability, oculomotor disturbances, and dementia.


A 70-year-old woman was admitted to hospital because of bilateral pleural effusion, and referred to our neurology department due to a 2-year history of gait disturbance that occasionally resulted in falling down, before which she had been well. Six months after the first episode of falling down, her family noticed that she had a masked face, monotonous speech, and bradykinesia in both arms and legs. During the subsequent year she fell down more frequently, and she could not walk without assistance. She had been taking vitamin D and a calcium preparation to treat a 10-year history of idiopathic hypoparathyroidism and recurrent compression fracture of the thoracic and lumbar vertebral bodies. There was no family history of parkinsonism or any neurological disorders.

On examination, she was oriented to place and people, but had difficulty copying, calculating, and maintaining attention. A neuropsychological investigation showed a severe impairment in memory function, reduced psychomotor speed, and visuospatial dysfunction (Table 1). She had a decreased blink rate, a paucity of movement of the face, and mild dysarthria. Horizontal voluntary saccades were slightly limited and hypometric, and vertical upward and downward saccades were extremely limited and slow. Similarly, pursuit movements were full horizontally, but restricted on vertical gaze. She had a full range of eye movement in the doll's head maneuver, demonstrating that her gaze palsy was caused by a supranuclear problem. Other cranial nerve functions were normal. All four limbs exhibited bradykinesia and rigidity. Sitting up in a bed resulted in spontaneous retropulsion. She stood on a narrow base, and her stride was reduced with decreased arm swing bilaterally. She showed postural instability, and mild hesitation when initiating gait. The deep tendon reflexes were normoactive in all four limbs. However, there was no dystonia, pyramidal signs, or autonomic impairment.

Table 1
The neuropsychological findings of the patient

Laboratory studies at admission showed the following values: 6.6 mg/dL serum total calcium (normal: 8.6 to 10.0 mg/dL), 4.99 mg/dL phosphate (normal: 2.7 to 4.5 mg/dL), 52 U/L alkaline phosphatase (normal: 25 to 100 U/L), and 1.44 pg/mL intact-parathyroid hormone (normal: 13.0 to 54.0 pg/mL). Serum thyroxin and thyroid-stimulating hormone levels were normal. The electrocardiogram showed a prolonged QTc interval of 0.56 seconds.

Brain computed tomography (CT) demonstrated extensive, bilateral calcification of the basal ganglia, centrum semiovale, and bilateral dentate nuclei of the cerebellum (Fig. 1-A). On magnetic resonance imaging there were mixed high-and low-intensity signals compatible with the distribution of calcification on CT. The red nucleus and substantia nigra appeared normal (Fig. 1-B). Single-photon-emission computed tomography using 99mTc-hexamethylpropylene amineoxime showed no abnormal perfusion defects in the brain.

Figure 1
Computed tomography (CT) of the brain demonstrated extensive, bilateral calcification of the basal ganglia, centrum semiovale, and bilateral dentate nuclei of the cerebellum (A). Magnetic resonance imaging revealed mixed high- and low-intensity signals ...

Levodopa was started at 100 mg twice daily, and the dosage was slowly increased to 1000 mg per day. However, this did not produce any clinical improvement.


We experienced a case of striopallidodentate calcification associated with idiopathic hypoparathyroidism presenting with prominent oculomotor disturbances. The patient also showed parkinsonism that did not respond to levodopa treatment. The prominent oculomotor disturbances, in combination with these extrapyramidal features and dementia, suggested a clinical diagnosis of PSP.13

The origin of the parkinsonian symptoms and oculomotor disturbances of this patient is difficult to establish. One possibility is that the basal ganglia calcification observed in brain CT was an incidental finding, because asymptomatic basal ganglia calcifications may be seen at autopsy, especially in the elderly.14 However, the probability of such a coincidence is extremely low given the reported prevalence.15,16 In addition, it has been suggested that a metabolic disturbance such as low calcium or a high phosphorous plasma level may cause dopaminergic dysfunction in the substantia nigra pars compacta.17

18F-deoxyglucose and positron-emission tomography have shown that glucose metabolism in the basal ganglia and the frontal brain is massively reduced in Fahr's disease.9,18 This abnormality possibly results from a disruption of frontostriatal circuits, presumably at the level of the basal ganglia.9 The precise mechanism of oculomotor disturbance in our patient was unknown. In view of the co-occurrence of oculomotor abnormalities in other progressive basal ganglia disorders such as Parkinson's disease, PSP, and Huntington's disease, the significant impairment of eye movement in our patient may have been attributable to dysfunction of the basal ganglia in the generation of voluntary saccades.19

In conclusion, we have presented a rare case with idiopathic hypoparathyroidism complicated by oculomotor disturbances and parkinsonism with a PSP-like phenotype.


This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (project no. A060093).


1. Scotti G, Scialfa G, Tampieri D, Landoni L. MR imaging in Fahr disease. J Comput Assist Tomogr. 1985;9:790–792. [PubMed]
2. Manyam BV, Bhatt MH, Moore WD, Devleschoward AB, Anderson DR, Calne DB. Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies. Ann Neurol. 1992;31:379–384. [PubMed]
3. Kobari M, Nogawa S, Sugimoto Y, Fukuuchi Y. Familial idiopathic brain calcification with autosomal dominant inheritance. Neurology. 1997;48:645–649. [PubMed]
4. Geschwind DH, Loginov M, Stern JM. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease) Am J Human Genet. 1999;65:764–772. [PubMed]
5. Kim SH, Yoo BG, Kim KS, Yoo KM, Joh YD. Familial idiopathic striopallidodentate calcifications. J Korean Neurol Assoc. 2003;21:191–194.
6. Manyam BV, Walters AS, Narla KR. Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov Disord. 2001;16:258–264. [PubMed]
7. Trautner RJ, Cummings JL, Read SL, Benson DF. Idiopathic basal ganglia calcification and organic mood disorder. Am J Psychiatry. 1988;145:350–353. [PubMed]
8. Lopez-Villegas D, Kulisevsky J, Deus J, Junque C, Pujol J, Guardia E, et al. Neuropsychological alterations in patients with computed tomography-detected basal ganglia calcification. Arch Neurol. 1996;53:251–256. [PubMed]
9. Benke T, Karner E, Seppi K, Delazer M, Marksteiner J, Donnemiller E. Subacute dementia and imaging correlates in a case of Fahr's disease. J Neurol Neurosurg Psychiatry. 2004;75:1163–1165. [PMC free article] [PubMed]
10. Saver JL, Liu GT, Charness ME. Idiopathic striopallidodentate calcification with prominent supranuclear abnormality of eye movement. J Neuroophthalmol. 1994;14:29–33. [PubMed]
11. Galvez-Jimenez N, Hanson MR, Cabral J. Dopa-resistant parkinsonism, oculomotor disturbances, chorea, mirror movements, dyspraxia, and dementia: the expanding clinical spectrum of hypoparathyroidism. A case report. Mov Disord. 2000;15:1273–1276. [PubMed]
12. Calabrese VP, Hadfield MG. Parkinsonism and extraocular motor abnormalities with unusual neuropathological findings. Mov Disord. 1991;6:257–260. [PubMed]
13. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1–9. [PubMed]
14. Lowe J, Lennox G, Leigh PN. Disorders of movement disorders and system degenerations. In: Graham DI, Lantos PL, editors. Green-field's Neuropathology. 6th edn. Vol II. London: Arnold; 1997. pp. 281–366.
15. Bronsky D, Kushner DS, Dubin A, Snapper I. Idiopathic hypoparathyroidism and pseudohypoparathyroidism: case reports and review of the literature. Medicine. 1958;37:317–352. [PubMed]
16. Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, et al. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain. 2001;124:1438–1449. [PubMed]
17. Vaamonde J, Legarda I, Jimenez-Jimenez J, Zubieta JL, Obeso JA. Levodopa-responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism. Mov Disord. 1993;8:398–400. [PubMed]
18. Hempel A, Henze M, Berghoff C, Garcia N, Ody R, Schroder J. PET findings and neuropsychological deficits in a case of Fahr's disease. Psychiatry Res. 2001;108:133–140. [PubMed]
19. Hikosaka O, Takikawa Y, Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev. 2000;80:953–978. [PubMed]

Articles from Journal of Clinical Neurology (Seoul, Korea) are provided here courtesy of Korean Neurological Association